A long-term follow-up study investigating health-related quality of life and resource use in survivors of severe sepsis: comparison of recombinant human activated protein C with standard care. [electronic resource]
- Critical care (London, England) 2007
- R128 p. digital
Adult Aged Cohort Studies Female Follow-Up Studies Humans Longitudinal Studies Male Middle Aged Patient Acceptance of Health Care Protein C--therapeutic use Quality of Life Recombinant Proteins--therapeutic use Sepsis--mortality Survival Rate--trends